From: Hepatitis E outbreak in the health district of Bocaranga-Koui, Central African Republic, 2018–2019
IgM anti-HEV | IgG anti-HEV | |||||||
---|---|---|---|---|---|---|---|---|
Characteristics | Positive, No. (%) | Negative, No. (%) | OR (95% CI) | P | Positive, No. (%) | Negative, No. (%) | OR (95% CI) | P |
Prevalence | 142 (40.3) | 204 (57.9) | 175 (49.7) | 163 (46.3) | ||||
Sex | 0.39 | 0.65 | ||||||
Male | 70 (38.9) | 110 (61.1) | 87 (50.6) | 85 (49.4) | ||||
Female | 72 (43.3) | 94 (56.7) | 88 (53.0) | 78 (47.0) | ||||
Age group | 0.001 | 0.001 | ||||||
0–10 | 16 (14.9) | 91 (85.1) | - | 18 (17.9) | 83 (82.1) | - | ||
11–20 | 27 (42.1) | 37 (57.9) | 4.1 (2.0–8.6) | 0.001 | 37 (56.0) | 29 (44.0) | 5.8 (2.9–11.8) | 0.001 |
21–30 | 42 (59.1) | 29 (40.9) | 8.3 (4.0–16.9) | 0.001 | 51 (71.9) | 20 (28.1) | 11.7 (5.6–24.3) | 0.001 |
31–40 | 25 (49.0) | 26 (51.0) | 5.5 (2.5–11.8) | 0.001 | 31 (63.2) | 18 (36.8) | 7.9 (3.6–17.1) | 0.001 |
> 40 | 32 (61.5) | 20 (38.5) | 9.2 (4.2–19.8) | 0.001 | 38 (74.5) | 13 (25.5) | 13.4 (5.9–30.3) | 0.001 |
ASTa, IU/L | 0.001 | 0.19 | ||||||
< 15 | 2 (18.1) | 9 (67.0) | 0.5(0.1–2.5) | 0.40 | 2(22.2) | 7(77.7) | 0.90 | |
15–46 | 28 (30.4) | 64(72.4) | - | 49(53.8) | 42(46.1) | |||
> 46 | 112 (46.0) | 131(50.0) | 1.9(1.1–3.2) | 0.01 | 124(52.1) | 114(47.9) | 0.91 | |
ALTb, IU/L | 0.001 | 0.001 | ||||||
< 11 | 7 (25) | 21 (75) | 1.0 (0.4–2.7) | 0.41 | 09(36) | 16(64) | 0.7(0.3–1.7) | 0.49 |
11–66 | 41 (23.7) | 132 (76.3) | - | 73 (43.2) | 96(56.8) | - | ||
> 66 | 94 (64.8) | 51 (35.1) | 5.9 (3.6–9.7) | 0.001 | 93(64.5) | 51(35.4) | 2.3(1.5–3.7) | 0.001 |